lupus
Ampel BioSolutions Building Evidence for Prognostic Potential of Lupus Molecular Subtyping Test
Premium
The company recently used its blood-based LuGene test to identify eight lupus molecular subtypes that may be used to predict flare-ups and therapy response.
Systemic Sclerosis Study Highlights Immune-Related Genetic Risk Loci
Researchers found six new systemic sclerosis risk variants in a Japanese GWAS and cross-ancestry meta-analysis, including B cell-related regulatory variants.
Ampel BioSolutions Developing Molecular Test to Predict Kidney Damage in Lupus Nephritis Patients
Premium
The test may also be able to identify patients who are most likely to respond to the 45 different drugs for lupus nephritis that are in clinical trials.
Ampel will use the signature to develop FibroGene, a fibromyalgia blood test that the company expects to launch next year.
Evotec, Hannover Medical School Partner on Multiomic Autoimmune Disease Patient Database
The German medical school will analyze samples from hundreds of Sjögren's and systemic lupus erythematosus patients in search of new treatment pathways.